Article
Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV.
The Journal of antimicrobial chemotherapy - 1 May 2012
Rallón Norma I, Soriano Vincent, Naggie Susanna, Restrepo Clara, McHutchison John, Vispo Eugenia, Benito José M
Abstract excerpt
OBJECTIVES: The mechanism explaining the strong association between IL28B rs12979860 polymorphisms and treatment outcome in chronic hepatitis C remains unclear. We explore whether IL28B protein [interferon (IFN)-λ3] plasma levels may vary according to IL28B genotype and/or following pegylated IFN-α/ribavirin therapy. PATIENTS AND METHODS: A total of 112 HIV/hepatitis C virus (HCV)-coinfected patients who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
